Background Active surveillance (AS) represents a standard of care of low‐risk prostate
cancer (PCa). However, the identification and monitoring of AS candidates remains …

Simple Summary Prostate cancer (PCa) aggressiveness can be assessed from clinical and
pathologic surrogate endpoints as the International Society of Uropathology grade group …

Objective The aim of this study was to quantify radiomic changes in prostate cancer (PCa)
progression on serial MRI among patients on active surveillance (AS) and evaluate their …

Purpose: To develop a deep learning-based method to retrospectively quantify T2 from
conventional T1-and T2-weighted images. Methods: Twenty-five subjects were imaged …

Purpose: This study aimed to assess the medium-term oncologic outcomes of an active
surveillance protocol, replacing confirmatory biopsy with serial multiparametric magnetic …

COVID-19 transmission during prostate procedures is possible. Patients with a Prostate
Imaging-Reporting and Data System (PI-RADS) of< 3 and PSA density< 0.15 ng/ml/ml are …

Active surveillance (AS) is a management strategy aiming at avoiding overtreatment of a
newly diagnosed lowrisk prostate cancer until there is evidence of disease progression at …

Objective To demonstrate the added benefit of multiparametric (mp) MRI risk stratification
during active surveillance. Methods This prospective, single-arm, nonrandomized study …

Purpose: Less invasive decision support tools are desperately needed to identify occult high-
risk disease in men with prostate cancer (PCa) on active surveillance (AS). For a variety of …

Active surveillance serves as a vital management strategy for patients diagnosed with low-
risk, organ-confined prostate cancer and is aimed at reducing overtreatment, cost …